7 must-reads for supply chain leaders this week

Here are seven articles published by Becker's Hospital Review in the past week that offer insight on controversy surrounding the drug industry, the benefits of a career in supply chain and more.

1. Trump slams drugmakers at press conference: 'They're getting away with murder'
President-elect Donald Trump described the drug industry as "disastrous" and criticized current industry practices on Wednesday.

2. Director of supply chain named one of best jobs in America by CNNMoney
CNNMoney and PayScale named director of supply chain management to their list of the best jobs in America.

3. National Cancer Institute unveils ambitious program to hasten drug research
The National Cancer Institute is creating an ambitious new program that will enable scientists to access new drugs and compounds faster for medical research.

4. AbbVie CEO pledges to rein in price hikes
Richard Gonzalez, the CEO of AbbVie, said the company will not raise drug prices past the single digits in 2017.

5. 6 noteworthy drugs the FDA approved in 2016
Here are six noteworthy drugs the Food and Drug Administration approved in 2016.

6. Amazon wins patent for underground delivery system using tunnels
Amazon won a patent for a system to deliver packages through a network of underground tunnels.

7. St. Jude Medical releases cybersecurity updates for vulnerable heart devices
St. Jude Medical, which Abbott Laboratories acquired in 2016, is releasing new cybersecurity updates for its implanted heart devices. The move comes five months after a government launched an investigation into the devices over claims they were vulnerable to dangerous hacks

More articles on supply chain:

AbbVie CEO pledges to rein in price hikes
National Cancer Institute unveils ambitious program to hasten drug research
Op-ed: The 1 way pharma can get on Trump's good side

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars